{"id":4062,"date":"2010-10-22T11:04:13","date_gmt":"2010-10-22T15:04:13","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?p=4062"},"modified":"2011-07-19T17:44:45","modified_gmt":"2011-07-19T21:44:45","slug":"dabigatran-resource-round-up","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2010\/10\/22\/dabigatran-resource-round-up\/","title":{"rendered":"Dabigatran Resource Round-Up"},"content":{"rendered":"<p>Our coverage of the FDA&#8217;s approval of dabigatran for the prevention of stroke and blood clots in patients with AF has triggered a flurry of comments from CardioExchange members, including questions about when dabigatran will be available, how much it will cost, who should \u2014 and shouldn&#8217;t \u2014 receive it, and what dosages should be prescribed. Check out our dabigatran round-up below and tell us what you think: All future dabigatran comments will reside here. Oh, and by the way, how do <em>you<\/em> pronounce dabigatran?<\/p>\n<ul>\n<li><a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/dabigatran-vs-warfarin-war-or-peace\/\">Dabigatran vs Warfarin: War or Peace?<\/a><\/li>\n<li><a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/fda-approves-dabigatran-for-stroke-prevention-in-atrial-fibrillation\/\">FDA Approves Dabigatran for Stroke Prevention in Atrial Fibrillation<\/a><\/li>\n<li><a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/dabigatran-is-approved\/\">Dabigatran Is Approved<\/a><\/li>\n<li><a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/finally-dabigatran-a-new-oral-anticoagulant-is-approved-by-the-fda\/\">Finally: Dabigatran &#8211; A New Oral Anticoagulant Is Approved by the FDA<\/a><\/li>\n<li><a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/lets-call-the-whole-thing-off\/\">Let&#8217;s Call the Whole Thing Off!<\/a><\/li>\n<li><a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/what-do-i-plan-to-do-with-dabigatran\/\">What Do I Plan to Do with Dabigatran?<\/a><\/li>\n<li><a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/warfarin-or-dabigatran-the-thick-and-thin-of-deciding-on-an-anticoagulant\/\">Warfarin or Dabigatran? The Thick and Thin of Deciding on an Anticoagulant<\/a><\/li>\n<li><a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/dabigatran-to-cost-237-per-month-at-the-drugstore\/\">Dabigatran to Cost $237 per Month at the Drugstore<\/a><\/li>\n<li><a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/is-dabigatran-more-cost-effective-than-warfarin-in-af\/\">Is Dabigatran More Cost-Effective Than Warfarin in AF?<\/a><\/li>\n<li><a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/re-ly-substudy-finds-dabigatran-effective-in-secondary-stroke-prevention\/\">RE-LY Substudy Finds Dabigatran Effective in Secondary Stroke Prevention<\/a><\/li>\n<li><a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/looking-back-at-2010\/\">A Look Back at 2010<\/a><\/li>\n<li><a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/af-guidelines-updated-to-incorporate-dabigatran\/\">AF Guidelines Updated to Incorporate Dabigatran<\/a><\/li>\n<li><a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/dabigatran-for-patients-with-afib-putting-the-updated-recs-into-practice\/\">Dabigatran for Patients with AFib: Putting the Updated Recs into Practice<\/a><\/li>\n<li><a href=\"http:\/\/blogs.nejm.org\/cardioexchange\/dabigatran-dialog-two-experts-answer-our-questions-and-yours\/\">Dabigatran Dialogue: Two Experts Answer Our Questions and Yours<\/a><\/li>\n<\/ul>\n<div id=\"_mcePaste\" class=\"mcePaste\" style=\"position: absolute; left: -10000px; top: 129px; width: 1px; height: 1px; overflow: hidden;\">\n<h2 class=\"posttitle\"><a title=\"Permanent Link to RE-LY Substudy Finds Dabigatran Effective in Secondary Stroke Prevention\" rel=\"bookmark\" href=\"..\/re-ly-substudy-finds-dabigatran-effective-in-secondary-stroke-prevention\/\">RE-LY Substudy Finds Dabigatran Effective in Secondary Stroke Prevention<\/a><\/h2>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Our coverage of the FDA&#8217;s approval of dabigatran for the prevention of stroke and blood clots in patients with AF has triggered a flurry of comments from CardioExchange members, including questions about when dabigatran will be available, how much it will cost, who should \u2014 and shouldn&#8217;t \u2014 receive it, and what dosages should be [&hellip;]<\/p>\n","protected":false},"author":343,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-4062","post","type-post","status-publish","format-standard","hentry","category-general"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/4062","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/343"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=4062"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/4062\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=4062"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=4062"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=4062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}